Ultralife Corporation (NASDAQ:ULBI) Q4 2020 Earnings Conference Call February 4, 2021 8:30 AM ET Company Participants Jody Burfening – Investor Relations Mike Popielec – President and Chief Executive Officer Phil Fain – Chief Financial Officer Conference Call Participants Gary Siperstein – Eliot Rose Wealth Management Operator Good day, and welcome to the Ultralife Corporation Fourth Quarter 2020 Earnings Release Conference Call. At this time, for opening remarks and introductions, I’d like to turn the call ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or other ...

Ultralife Corporation. (NASDAQ:ULBI) Q3 2020 Results Earnings Conference Call October 29, 2020 8:30 AM ET Company Participants Jody Burfening - Lippert/Heilshorn & Associates, Inc. Michael Popielec - CEO and President Philip Fain - CFO, Treasurer, and Corporate Secretary Conference Call Participants Gary Siperstein - Eliot Rose Wealth Management Operator Good day and welcome to the Ultralife Corporation Third Quarter 2020 Earnings Release Conference Call. Today’s conference is being recorded. At this time, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from ____________ to ____________ FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ULTRALIFE CORPORATION 2000 Technology Parkway Newark, New York 14513 (Address of principal executive offices) (Zip Code) (I.R ...

Ultralife Corporation (NASDAQ:ULBI) Q2 2020 Earnings Conference Call July 30, 2020 8:30 AM ET Company Participants Jody Burfening - Lippert/Heilshorn & Associates, Inc. Michael D. Popielec - CEO and President Philip A. Fain - CFO, Treasurer, and Corporate Secretary Conference Call Participants Gary Siperstein - Eliot Rose Asset Management Operator Good day and welcome to the Ultralife Corporation Second Quarter 2020 Earnings Release Conference Call. At this time, for opening remarks and introductions, I'd ...

Ultralife Corporation Investor Presentation Michael D. Popielec PRESIDENT & CEO Philip A. Fain CFO & TREASURER Updated July 30, 2020 1 IMPORTANT REMINDER – FORWARD LOOKING STATEMENTS This presentation may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number: 0-20852 ULTRALIFE CORPORATION (Exact name of registrant as specified in its charter) Delaware (State or ot ...

Ultralife Corporation (NASDAQ:ULBI) Q1 2020 Earnings Conference Call April 30, 2020 8:30 AM ET Company Participants Jody Burfening – Investor Relations Mike Popielec – President and Chief Executive Officer Phil Fain – Chief Financial Officer Conference Call Participants Gary Siperstein – Eliot Rose Wealth Management Operator Good day, and welcome to the Ultralife Corporation First Quarter 2020 Earnings Release Conference Call. As a reminder, today’s call is being recorded. At this time, for opening remarks ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Delaware (State or other jurisdiction of incorporation of organization) 2000 Technology Parkway Newark, New York 14513 (Address o ...

Ultralife Corporation (NASDAQ:ULBI) Q4 2019 Earnings Conference Call February 6, 2020 8:30 AM ET Company Participants Jody Burfening - Investor Relations Mike Popielec - President & Chief Executive Officer Phil Fain - Chief Financial Officer Conference Call Participants Operator Good day, ladies and gentlemen, and welcome to this Ultralife Corporation Fourth Quarter 2019 Earnings Release Conference Call. At this time for opening remarks and introductions, I'd like to turn the call over to Ms. Jody Burfening ...